Skip to main content
Premium Trial:

Request an Annual Quote

Dolomite to Collaborate on EU-funded Microfluidics Tech for Stem Cells

NEW YORK (GenomeWeb News) – UK-based microfluidics developer Dolomite said today that it will collaborate with the Danish firms Bioneer and OptoRobotix in a European Union-funded effort to develop a new stem cell handling device.

The consortium has received €820,100 ($1.1 million) from the EU's Eurostars program to fund the two-year project, which aims to develop a microfluidic tool that could be used in molecular biology, biotechnology, and pharmaceutical applications.

The OPTISORT platform will be a sorting and analysis tool that uses optical and droplet technologies for sorting fragile mammalian cells. It will enable stem cell biology and mammalian cell-based protein manufacturing, which the company said are both fast-developing fields.

OptoRobotix develops flow cytometers with cell sorting capabilities. Bioneer, a subsidiary of the Technical University of Denmark, provides access to tools to facilitate therapeutic, cellular, and molecular biology projects.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.